CClinicalTrials.gg
Not yet recruitingNCT07241143ExPeTuDUpdated Nov 21, 2025

Extra-Peritoneal Tunneling Versus Conventional Drain Fixation After Anterior or Low Anterior Resection

An interventional study of EPT drain fixation and Conventional drain insertion in Rectal Diseases, Sigmoid Colon Disease and Rectal Cancer, Sigmoid Colon Cancer, sponsored by Yeungnam University Hospital. Not yet recruiting at 1 site in South Korea. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by Yeungnam University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
596
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether the extra-peritoneal tunneling (EPT) drain fixation method works better and more safely than the conventional drain insertion method after rectal cancer surgery.

It will also learn about the safety and possible complications of the EPT technique.

The main questions it aims to answer are:

Does the EPT drain fixation method increase the success rate of conservative management (drain maintenance and/or antibiotics) when an anastomotic leak occurs?

Does the EPT method reduce the rate of drain displacement compared with the conventional method?

Are there any safety concerns or complications associated with the EPT method?

Researchers will compare EPT drain fixation to the conventional drain method to see which approach provides better outcomes after anterior or low anterior resection for rectal cancer.

Participants will:

Undergo anterior or low anterior resection for rectal cancer as part of their standard surgical treatment.

Be randomly assigned to either the EPT drain fixation group or the conventional drain group.

Receive the same postoperative care as usual, including follow-up imaging to monitor drain position and recovery.

Be observed for postoperative outcomes such as anastomotic leakage, drain position, and related complications until recovery.

This study will help determine whether securing the drain through an extra-peritoneal tunnel can prevent drain movement, improve early management of leakage, and enhance patient recovery after rectal surgery.

Read the detailed description

resection for rectal cancer. Although prophylactic pelvic drainage has been widely used to detect early leakage and to prevent pelvic sepsis, recent randomized trials and meta-analyses have reported that routine drain placement provides no significant benefit in reducing postoperative morbidity. One possible reason is drain displacement, which occurs in up to 30-40% of cases, resulting in the drain being positioned far from the anastomotic site and losing its intended function.

The extra-peritoneal tunneling (EPT) drain fixation method is a new surgical technique designed to prevent drain displacement by creating an extraperitoneal tunnel that anchors the drain securely near the anastomosis. This technique is performed using the Drain-TG™ (DTG) device developed by JSR Medical (Daegu, Korea). Preliminary retrospective data have shown that the EPT technique dramatically reduces drain displacement (2.8% vs. 40% with conventional insertion, p \< 0.001) and that, in patients who developed AL, the success rate of conservative management (drain maintenance and antibiotics only) exceeded 80%, compared with 43% in the conventional group.

The ExPeTuD trial is a prospective, multi-center, randomized controlled trial that aims to establish strong evidence for the efficacy and safety of the EPT drain fixation method. Patients undergoing anterior or low anterior resection with a predicted anastomosis ≤ 10 cm from the anal verge will be enrolled from approximately 20 tertiary hospitals across Korea. Participants will be randomized 1:1 to either the EPT group or the conventional drain group, stratified by sex, tumor level (above vs. below the peritoneal reflection), and preoperative chemoradiation status.

The primary outcome is the success rate of conservative management (drain maintenance and/or antibiotics) for AL according to drain insertion method. Secondary outcomes include:

Rate and timing of drain displacement (defined as > 3 cm separation from the anastomotic site on X-ray),

Drain-related complications (infection, pain, bleeding, or organ injury),

Time to diagnosis of AL and time to re-intervention,

Postoperative recovery outcomes such as ileus, hospital stay, and overall morbidity (Clavien-Dindo classification).

Radiologic monitoring (abdominal X-rays on postoperative days 2, 4, and 6) will be performed to assess drain position, and additional imaging will be conducted if AL is suspected. Standard postoperative care, including enhanced recovery after surgery (ERAS) protocols, will be applied equally to both groups.

A total of 596 participants (298 per arm) will be recruited, which accounts for an expected 6% AL rate after low anterior resection and ensures sufficient power for superiority testing. Interim analysis will be conducted once ≥ 9 AL events occur in each group to assess safety and trial feasibility.

If the EPT drain fixation method proves effective in maintaining drain position and improving conservative management success rates, it could reduce the need for reoperation, shorten hospital stay, and improve patient outcomes after rectal cancer surgery. This trial aims to provide robust clinical evidence supporting the adoption of the EPT technique as a standard method for pelvic drainage following proctectomy.

02

Conditions studied

  • Rectal Diseases, Sigmoid Colon Disease
  • Rectal Cancer, Sigmoid Colon Cancer

Keywords

  • drain, anterior resection, low anterior resection
03

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients scheduled to undergo rectal resection (anterior resection or low anterior resection) with planned intraoperative drain placement.
  • Expected anastomotic level ≤10 cm from the anal verge based on preoperative imaging or endoscopic evaluation.

Exclusion criteria

Exclusion Criteria:

  • Patients scheduled to undergo additional colonic resection (e.g., right hemicolectomy, transverse colectomy).
  • Patients in whom no intraoperative drain placement is planned.
  • Patients scheduled for permanent or end stoma formation (e.g., abdominoperineal resection or Hartmann's procedure).
  • Patients with prior pelvic surgery (e.g., hysterectomy, prostatectomy, pelvic lymph node dissection) that may cause pelvic adhesions or anatomic distortion.
  • Patients with ASA physical status IV or severe systemic disease expected to require postoperative intensive care unit (ICU) admission.
  • Patients who decline to provide informed consent for study participation
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
596 participants (estimated)

Study arms

  • Active comparator
    Conventional drain insertion

    Participants undergo standard transperitoneal pelvic drain placement following anterior or low anterior resection.

    Procedure: Conventional drain insertion

  • Experimental
    EPT drain fixation

    Participants undergo pelvic drain placement using the extra-peritoneal tunneling (EPT) method following anterior or low anterior resection.

    Procedure: EPT drain fixation

Interventions

  • ProcedureEPT drain fixation

    Participants in this arm will receive pelvic drain placement using the extra-peritoneal tunneling (EPT) drain fixation method after anterior or low anterior resection for rectal cancer. The drain is then passed through this tunnel and positioned close to the anastomosis to maintain stable drainage and prevent displacement

  • ProcedureConventional drain insertion

    Participants in this arm will receive pelvic drain placement using the conventional transperitoneal method after anterior or low anterior resection for rectal cancer. In this standard technique, the drain is inserted directly through a lower abdominal port site (usually the left lower quadrant) into the pelvic cavity without creating an extraperitoneal tunnel

05

What researchers measure

Primary outcomes

  1. Rate of successful conservative management in patients who developed an anastomotic leak

    The success of conservative management is defined as resolution of the anastomotic leak without the need for reoperation or diversion. Success rates will be compared between patients managed with the Extra-Peritoneal Tunneling (EPT) drain fixation method and those with the conventional intraperitoneal drain placement.

    Time frame: Within 60 days after diagnosis of anastomotic leak

Secondary outcomes

  1. Incidence of drain displacement according to drain fixation method

    Drain displacement is defined as any unintended displacement of the drain from the originally intended position, confirmed by radiologic verification (X-ray or CT). Drain displacement is defined as a drain-to-anastomosis shortest distance exceeding 3 cm on an radiologic imaging compared with the immediate postoperative position. Incidence (%) of displacement will be compared between the Extra-Peritoneal Tunneling (EPT) and conventional drain fixation groups.

    Time frame: Up to drain removal, an average of 7 days

  2. Time to drain displacement (days)

    Defined as the number of days from surgery to the date when drain displacement (drain-to-anastomosis shortest distance \>3 cm on erect abdominal view) is first observed.

    Time frame: Up to drain removal, an average of 7 days

  3. Incidence and types of drain-related complications according to drain fixation method

    Includes any adverse events directly related to the drain, such as infection at the insertion site, pain, skin irritation, etc.

    Time frame: Up to drain removal, an average of 7 days

  4. Early detection of anastomotic leak (days from surgery to diagnosis)

    Evaluates whether the use of EPT drain fixation facilitates earlier identification of anastomotic leak. Measured as the number of days from surgery to the confirmed diagnosis of anastomotic leak.

    Time frame: Time to anastomotic leak, assessed up to 90 days after surgery

  5. Interval between anastomotic leak diagnosis and reoperation (hours)

    Measures the time interval between the diagnosis of anastomotic leak and reoperation, including documentation of whether the reoperation occurred as an emergency or elective procedure.

    Time frame: Time from leak diagnosis to reoperation, assessed up to 30 days after leak diagnosis

06

Study locations

1 site
  • Sung Il Kang
    Daegu, South Korea
07

References and documents

Individual participant data

Plan to share: Undecided — We have not yet determined whether individual participant data (IPD) will be shared. If sharing is approved, only de-identified IPD related to primary and key secondary outcomes will be made available.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07241143
Lead sponsor
Yeungnam University Hospital
Collaborators
Konyang University Hospital, Daegu Catholic University Medical Center, Seoul National University Bundang Hospital, Samsung Medical Center, Seoul National University Hospital, Severance Hospital, Chungnam National University Hospital, Chungbuk National University Hospital, Keimyung University Dongsan Medical Center, Pusan National University Yangsan Hospital, Chonbuk National University Hospital, Kyungpook National University Chilgok Hospital, Yonsei University Yongin Severance Hospital, Chonnam National University Hospital, Ewha Womans University Seoul Hospital, Soonchunhyang University Hospital, Hallym University Dongtan Sacred Heart Hospital
Responsible party
Sung il Kang (Associate Professor, Yeungnam University Hospital) — Principal investigator
First posted
Nov 21, 2025
Start date
Dec 1, 2025 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Feb 28, 2029 (estimated)
Last update
Nov 21, 2025

Study contacts

SUNG IL KANG, M.D., Ph.D.
Contact
sungiry@naver.com
+82-10-9124-5085
Jihye Lee
Contact
sungiry@naver.com
+82-53-620-3580
SUNG IL KANG, M.D., Ph.D.
principal investigator · Yeungnam University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion